Diabetes decisions — 2025

The Board remands the claims for a rating in excess of 20 percent for diabetes mellitus, type II and prostate cancer, service connection for osteoarthritis of both knees, pseudophakia (claimed as vision), and entitlement to TDIU due to pre-decisional duty to assist errors.

The Board remands the claims for service connection for heart condition, diabetes mellitus, and peripheral neuropathy, as well as the claim for special monthly compensation (SMC) based on aid and attendance/housebound status, due to a pre-decisional duty to assist error.

The Board granted service connection and ratings for the veteran's diabetes mellitus type II, arteriosclerotic heart disease, hypertension, and diabetic peripheral neuropathy of both lower extremities.

The Board denied benefits for a child born with birth defects and spina bifida under 38 U.S.C. § 1805, as the appellant's mother is not a Vietnam veteran and there is no evidence of a diagnosis of spina bifida.

The Board granted a 40 percent rating for peripheral neuropathy of the right and left lower extremities prior to April 21, 2021, but denied ratings in excess of 50 percent for PTSD and 40 percent for peripheral neuropathy since that date.

The Veteran withdrew his appeals for service connection for hypertension and diabetes mellitus type II, as secondary to his service-connected bilateral knee disabilities.

The Board granted service connection for ischemic heart disease, hypertension, and diabetes mellitus under the PACT Act. The Veteran's kidney and bilateral eye disabilities were also granted as secondary to his now-service-connected diabetes mellitus.

The Board denied service connection for diabetes mellitus, type II as the evidence did not show that it was chronic in service or manifested to a compensable degree within one year of discharge; nor was there continuity of symptomatology since service.

The Board remands the issues of service connection for diabetes mellitus, hypertension, erectile dysfunction, and residuals of prostate cancer due to further development needed regarding exposure to non-herbicide agent contaminants at Fort Dix.

The Board denied service connection for right and left knee disabilities, to include osteoarthritis (OA), as well as diabetes mellitus, Type II (DM II) and peripheral artery disease (PAD).

The Board remands the veteran's claims for service connection for various disabilities, including chloracne, diabetes, peripheral neuropathy, major depressive disorder, hypertension, erectile dysfunction, and a kidney disability, to obtain further development in accordance with the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxins Act of 2022 (PACT Act).

The Board denied service connection for an acquired psychiatric disorder, to include PTSD, and diabetes mellitus, type II, as the evidence did not support a finding of a current disability related to service.

The Board remands the matter for an addendum medical opinion to address whether the Veteran's diabetes is caused by or aggravated by his service-connected disabilities, including hypertension. Additionally, a TERA examination is required due to the Veteran's participation in toxic risk exposure activities during his ACDUTRA.

The Board granted service connection for diabetes mellitus type II, hypertension, and prostate cancer on a direct basis, effective August 10, 2022.

The Board remands the issues of entitlement to service connection for left and right foot sensorimotor peripheral neuropathy, as well as diabetes, due to a need for additional development.

The appeal was dismissed due to the Veteran's death while it was pending before the Board of Veterans' Appeals.

The Board remands the claims for service connection for various conditions, including a chronic liver disorder and diabetes mellitus, type II (DMII), due to insufficient medical evidence and required toxic exposure risk activity (TERA) opinions.

The Board denied service connection for diabetes and a prostate disorder as the evidence did not support a finding that these conditions were incurred in or aggravated by active service.

The Veteran's type II diabetes mellitus was granted an effective date of November 19, 2019, and a rating of 40 percent from that date. The claim for a higher rating was denied.

The Board denied the veteran's claim for a rating in excess of 20 percent for diabetes mellitus, type II, and remanded the issue of entitlement to a separate rating for erectile dysfunction.